Skip to main content
Top

12-10-2016 | Sarcoma | Article

Soft tissue sarcoma of the extremities: pending questions on surgery and radiotherapy

Journal: Radiation Oncology

Authors: Fien Hoefkens, Charlotte Dehandschutter, Johan Somville, Paul Meijnders, Dirk Van Gestel

Publisher: BioMed Central

Abstract

Soft tissue sarcomas are uncommon tumours of mesenchymal origin, most commonly arising in the extremities. Treatment includes surgical resection in combination with radiotherapy. Resection margins are of paramount importance in surgical treatment of soft tissue sarcomas but unambiguous guidelines for ideal margins of resection are still missing as is an uniform guideline on the use of radiotherapy.
The present paper reviews the literature on soft tissue sarcomas of the extremities regarding the required resection margins, the impact of new radiotherapy techniques and the timing of radiotherapy, more particularly if it should be administered before or after surgical resection.
This review was started by searching guidelines in different databases (National Guideline Clearinghouse, EBMPracticeNet, TRIP database, NCCN guidelines,…). After refinement of the query, more specific articles were found using MEDLINE, PubMed, Web of Science and Google Scholar. Used keywords include “soft tissue sarcoma”; “extremities OR limbs”; “radiotherapy”, “surgery”, “margins”, “local recurrence” and “overall survival”. Finally, the articles were selected based on the accessibility of the full text, use of the English language and relevance based on title and abstract.
Literature demonstrates positive resection margins to be an important adverse prognostic factor for local recurrence of soft tissue sarcomas of the extremities. Still, no consensus is reached on the definition of what a good margin might be. The evolution of new radiation techniques, especially Intensity Modulated Radiotherapy, resulted in a s healthy surrounding tissues. However, the timing of radiotherapy treatment remains controversial as both preoperative and postoperative radiotherapy are characterised by several advantages and disadvantages.
Literature
1.
Morrison BA. Soft tissue sarcomas of the extremities. Proceedings. 2003;16(3):285–90. Pubmed Central PMCID: 1200782.
2.
Group EESNW. Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23 Suppl 7:vii92–9.
3.
von Mehren M, Lor Randall R, DeLaney T, George S, Riedel R, Scheutze S, et al. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Soft Tissue Sarcoma. 2014;2.2014:126.
4.
Tran QN, Kim AC, Gottschalk AR, Wara WM, Phillips TL, O'Donnell RJ, et al. Clinical outcomes of intraoperative radiation therapy for extremity sarcomas. Sarcoma. 2006;2006(1):91671. Pubmed Central PMCID: 1557794, Epub 2006/10/17.PubMedPubMedCentral
5.
Rosenberg SA, Tepper J, Glatstein E, Costa J, Baker A, Brennan M, et al. The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg. 1982;196(3):305–15. Pubmed Central PMCID: 1352604, Epub 1982/09/01.CrossRefPubMedPubMedCentral
6.
Yang JC, Chang AE, Baker AR, Sindelar WF, Danforth DN, Topalian SL, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol. 1998;16(1):197–203. Epub 1998/01/24.PubMed
7.
Pisters PW, Harrison LB, Leung DH, Woodruff JM, Casper ES, Brennan MF. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol. 1996;14(3):859–68.PubMed
8.
Clark MA, Thomas JM. Amputation for soft-tissue sarcoma. Lancet Oncol. 2003;4(6):335–42.CrossRefPubMed
9.
DeLaney TF, Trofimov AV, Engelsman M, Suit HD. Advanced-technology radiation therapy in the management of bone and soft tissue sarcomas. Cancer Control. 2005;12(1):27–35. Epub 2005/01/26.PubMed
10.
Alektiar KM, Brennan MF, Healey JH, Singer S. Impact of intensity-modulated radiation therapy on local control in primary soft-tissue sarcoma of the extremity. J Clin Oncol. 2008;26(20):3440–4. Epub 2008/07/10.CrossRefPubMed
11.
Pervaiz N, Colterjohn N, Farrokhyar F, Tozer R, Figueredo A, Ghert M. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer. 2008;113(3):573–81.CrossRefPubMed
12.
Look Hong NJ, Hornicek FJ, Harmon DC, Choy E, Chen YL, Yoon SS, et al. Neoadjuvant chemoradiotherapy for patients with high-risk extremity and truncal sarcomas: a 10-year single institution retrospective study. Eur J Cancer. 2013;49(4):875–83. Pubmed Central PMCID: 3777719.CrossRefPubMed
13.
Mahmoud O, Dosch A, Kwon D, Pitcher JD, Conway S, Benedetto P, et al. The impact of perioperative chemotherapy timing in conjunction with postoperative external-beam radiation therapy on extremity soft-tissue sarcomas outcome. Am J Clin Oncol. 2014.
14.
Schmitt T, Lehner B, Kasper B, Bischof M, Roeder F, Dietrich S, et al. A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcoma. BMC Cancer. 2011;11:510. Pubmed Central PMCID: 3248452.CrossRefPubMedPubMedCentral
15.
Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol. 1996;14(5):1679–89.PubMed
16.
Trovik CS, Bauer HC, Alvegard TA, Anderson H, Blomqvist C, Berlin O, et al. Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group Register. Eur J Cancer. 2000;36(6):710–6.CrossRefPubMed
17.
Eilber FC, Rosen G, Nelson SD, Selch M, Dorey F, Eckardt J, et al. High-grade extremity soft tissue sarcomas: factors predictive of local recurrence and its effect on morbidity and mortality. Ann Surg. 2003;237(2):218–26. Pubmed Central PMCID: 1522131.PubMedPubMedCentral
18.
Chao AH, Mayerson JL, Chandawarkar R, Scharschmidt TJ. Surgical management of soft tissue sarcomas: Extremity sarcomas. J Surg Oncol. 2014;111(5):540–5.CrossRefPubMed
19.
Kawaguchi N, Ahmed AR, Matsumoto S, Manabe J, Matsushita Y. The concept of curative margin in surgery for bone and soft tissue sarcoma. Clin Orthop Relat Res. 2004;419:165–72.CrossRefPubMed
20.
Goldblum RJ, Folpe AL, Weiss SW. Enzinger and Weiss’s soft tissue tumors. 6th ed. Philadelphia: Elsevier Saunders; 2013.
21.
Coindre JM. Grading of soft tissue sarcomas: review and update. Arch Pathol Lab Med. 2006;130(10):1448–53.PubMed
22.
Deneve JL, Messina JL, Bui MM, Marzban SS, Letson GD, Cheong D, et al. Cutaneous leiomyosarcoma: treatment and outcomes with a standardized margin of resection. Cancer Control. 2013;20(4):307–12.PubMedPubMedCentral
23.
Le Corre Y, Avenel-Audran M, Croue A, Steff M, Verret JL. Cutaneous angiosarcoma of the leg without lymphoedema. Ann Dermatol Venereol. 2008;135(6–7):488–91. Angiosarcome cutane de jambe sans lymphoedeme associe.CrossRefPubMed
24.
Kandel R, Coakley N, Werier J, Engel J, Ghert M, Verma S, et al. Surgical margins and handling of soft-tissue sarcoma in extremities: a clinical practice guideline. Curr Oncol. 2013;20(3):e247–54. Pubmed Central PMCID: 3671031.CrossRefPubMedPubMedCentral
25.
Wolfson AH. Preoperative vs postoperative radiation therapy for extremity soft tissue sarcoma: controversy and present management. Curr Opin Oncol. 2005;17(4):357–60.CrossRefPubMed
26.
Simon MS, Springfield DS. Surgery for bone and soft-tissue tumors: Lippincott Williams & Wilkins; 1997.
27.
Garcia del Muro Solans X, Martin Broto J, Lianes Barragan P, Cubedo Cervera R, SEOM. SEOM clinical guidelines for the management of adult soft tissue sarcomas. Clin Transl Oncol. 2012;14(7):541–4.CrossRefPubMed
28.
Sampo M, Tarkkanen M, Huuhtanen R, Tukiainen E, Bohling T, Blomqvist C. Impact of the smallest surgical margin on local control in soft tissue sarcoma. Br J Surg. 2008;95(2):237–43.CrossRefPubMed
29.
Stojadinovic A, Leung DH, Hoos A, Jaques DP, Lewis JJ, Brennan MF. Analysis of the prognostic significance of microscopic margins in 2,084 localized primary adult soft tissue sarcomas. Ann Surg. 2002;235(3):424–34. Pubmed Central PMCID: 1422449.CrossRefPubMedPubMedCentral
30.
Potter BK, Hwang PF, Forsberg JA, Hampton CB, Graybill JC, Peoples GE, et al. Impact of margin status and local recurrence on soft-tissue sarcoma outcomes. J Bone Joint Surg Am. 2013;95(20):e151.CrossRefPubMed
31.
Sugiura H, Nishida Y, Nakashima H, Yamada Y, Tsukushi S, Yamada K. Surgical procedures and prognostic factors for local recurrence of soft tissue sarcomas. J Orthop Sci. 2014;19(1):141–9.CrossRefPubMed
32.
Biau DJ, Ferguson PC, Chung P, Griffin AM, Catton CN, O'Sullivan B, et al. Local recurrence of localized soft tissue sarcoma: a new look at old predictors. Cancer. 2012;118(23):5867–77.CrossRefPubMed
33.
Dickinson IC, Whitwell DJ, Battistuta D, Thompson B, Strobel N, Duggal A, et al. Surgical margin and its influence on survival in soft tissue sarcoma. ANZ J Surg. 2006;76(3):104–9.CrossRefPubMed
34.
Lewis JJ, Leung D, Heslin M, Woodruff JM, Brennan MF. Association of local recurrence with subsequent survival in extremity soft tissue sarcoma. J Clin Oncol. 1997;15(2):646–52.PubMed
35.
Sabolch A, Feng M, Griffith K, Rzasa C, Gadzala L, Feng F, et al. Risk factors for local recurrence and metastasis in soft tissue sarcomas of the extremity. Am J Clin Oncol. 2012;35(2):151–7.CrossRefPubMed
36.
Gronchi A, Lo Vullo S, Colombo C, Collini P, Stacchiotti S, Mariani L, et al. Extremity soft tissue sarcoma in a series of patients treated at a single institution: local control directly impacts survival. Ann Surg. 2010;251(3):506–11.CrossRefPubMed
37.
Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS. Surgical margins and reresection in the management of patients with soft tissue sarcoma using conservative surgery and radiation therapy. Cancer. 2003;97(10):2544–53.CrossRefPubMed
38.
Kikuta K, Kubota D, Yoshida A, Suzuki Y, Morioka H, Toyama Y, et al. An analysis of factors related to recurrence of myxofibrosarcoma. Jpn J Clin Oncol. 2013;43(11):1093–104.CrossRefPubMed
39.
Novais EN, Demiralp B, Alderete J, Larson MC, Rose PS, Sim FH. Do surgical margin and local recurrence influence survival in soft tissue sarcomas? Clin Orthop Relat Res. 2010;468(11):3003–11. Pubmed Central PMCID: 2947688.CrossRefPubMedPubMedCentral
40.
Ipach I, Wingert T, Kunze B, Kluba T. Oncological outcome and prognostic factors in the therapy of soft tissue sarcoma of the extremities. Orthop Rev (Pavia). 2012;4(4):e34. Pubmed Central PMCID: 3626305.CrossRef
41.
Liu CY, Yen CC, Chen WM, Chen TH, Chen PC, Wu HT, et al. Soft tissue sarcoma of extremities: the prognostic significance of adequate surgical margins in primary operation and reoperation after recurrence. Ann Surg Oncol. 2010;17(8):2102–11.CrossRefPubMed
42.
Catton C, Rumble RB, Warde P, members of the IMRT Indications Expert Panel. The role of IMRT in soft-tissue sarcomas. 2010.
43.
Society AC. Sarcoma: adult soft tissue cancer. 2013.
44.
Bagaria SP, Ashman JB, Daugherty LC, Gray RJ, Wasif N. Compliance with National Comprehensive Cancer Network guidelines in the use of radiation therapy for extremity and superficial trunk soft tissue sarcoma in the United States. J Surg Oncol. 2014;109(7):633–8.CrossRefPubMed
45.
Leibel SA, Fuks Z, Zelefsky MJ, Wolden SL, Rosenzweig KE, Alektiar KM, et al. Intensity-modulated radiotherapy. Cancer J. 2002;8(2):164–76. Epub 2002/05/15.CrossRefPubMed
46.
De Neve W, De Gersem W, Madani I. Rational use of intensity-modulated radiation therapy: the importance of clinical outcome. Semin Radiat Oncol. 2012;22(1):40–9.CrossRefPubMed
47.
O'Sullivan B, Griffin AM, Dickie CI, Sharpe MB, Chung PW, Catton CN, et al. Phase 2 study of preoperative image-guided intensity-modulated radiation therapy to reduce wound and combined modality morbidities in lower extremity soft tissue sarcoma. Cancer. 2013;119(10):1878–84.CrossRefPubMed
48.
Wang J, Shu-lian W, Yong-wen S, Xin-fan L, Jing J, Wei-hu W, et al. Postoperative intensity modulated radiation therapy provided favorable local control in patients with soft tissue sarcoma of extremities and trunk. Int J Radiat Oncol Biol Phys. 2013;87(2):S64–5.CrossRef
49.
Folkert MR, Singer S, Brennan MF, Kuk D, Qin LX, Kobayashi WK, et al. Comparison of local recurrence with conventional and intensity-modulated radiation therapy for primary soft-tissue sarcomas of the extremity. J Clin Oncol. 2014;32(29):3236–41. Pubmed Central PMCID: 4178522.CrossRefPubMedPubMedCentral
50.
Wang D, Bosch W, Roberge D, Finkelstein SE, Petersen I, Haddock M, et al. RTOG sarcoma radiation oncologists reach consensus on gross tumor volume and clinical target volume on computed tomographic images for preoperative radiotherapy of primary soft tissue sarcoma of extremity in Radiation Therapy Oncology Group studies. Int J Radiat Oncol Biol Phys. 2011;81(4):e525–8. Pubmed Central PMCID: 3205346.CrossRefPubMedPubMedCentral
51.
Haas RL, Delaney TF, O'Sullivan B, Keus RB, Le Pechoux C, Olmi P, et al. Radiotherapy for management of extremity soft tissue sarcomas: why, when, and where? Int J Radiat Oncol Biol Phys. 2012;84(3):572–80.CrossRefPubMed
52.
Wang D, Bosch W, Kirsch DG, Al Lozi R, El Naqa I, Roberge D, et al. Variation in the gross tumor volume and clinical target volume for preoperative radiotherapy of primary large high-grade soft tissue sarcoma of the extremity among RTOG sarcoma radiation oncologists. Int J Radiat Oncol Biol Phys. 2011;81(5):e775–80. Pubmed Central PMCID: 3099246.CrossRefPubMedPubMedCentral
53.
Call JA, Stafford SL, Petersen IA, Haddock MG. Use of intraoperative radiotherapy for upper-extremity soft-tissue sarcomas: analysis of disease outcomes and toxicity. Am J Clin Oncol. 2014;37(1):81–5.CrossRefPubMed
54.
Nag S, Shasha D, Janjan N, Petersen I, Zaider M, American Brachytherapy Society. The American Brachytherapy Society recommendations for brachytherapy of soft tissue sarcomas. Int J Radiat Oncol Biol Phys. 2001;49(4):1033–43. Epub 2001/03/10.CrossRefPubMed
55.
Skowronek J, Piotrowski T. Pulsed dose rate brachytherapy: a method description and review of clinical application. Przegl Lek. 2002;59(1):31–6. Brachyterapia nowotworow metoda Pulsed Dose Rate--opis metody oraz przeglad wskazan do leczenia.PubMed
56.
Alektiar KM, Leung D, Zelefsky MJ, Healey JH, Brennan MF. Adjuvant brachytherapy for primary high-grade soft tissue sarcoma of the extremity. Ann Surg Oncol. 2002;9(1):48–56. Epub 2002/02/07.CrossRefPubMed
57.
Pellizzon AC. Evidence and clinical outcomes of adult soft tissue sarcomas of the extremities treated with adjuvant high-dose-rate brachytherapy - a literature review. J Contemp Brachytherapy. 2014;6(3):318–22. Pubmed Central PMCID: 4200188.CrossRefPubMedPubMedCentral
58.
Kamada T, Tsujii H, Blakely EA, Debus J, De Neve W, Durante M, et al. Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience. Lancet Oncol. 2015;16(2):e93–e100.CrossRefPubMed
59.
O'Sullivan B, Davis AM, Turcotte R, Bell R, Catton C, Chabot P, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet. 2002;359(9325):2235–41. Epub 2002/07/10.CrossRefPubMed
60.
Nielsen OS, Cummings B, O'Sullivan B, Catton C, Bell RS, Fornasier VL. Preoperative and postoperative irradiation of soft tissue sarcomas: effect of radiation field size. Int J Radiat Oncol Biol Phys. 1991;21(6):1595–9. Epub 1991/11/01.CrossRefPubMed
61.
Tseng JF, Ballo MT, Langstein HN, Wayne JD, Cormier JN, Hunt KK, et al. The effect of preoperative radiotherapy and reconstructive surgery on wound complications after resection of extremity soft-tissue sarcomas. Ann Surg Oncol. 2006;13(9):1209–15. Epub 2006/09/05.CrossRefPubMed
62.
Davis AM, O'Sullivan B, Bell RS, Turcotte R, Catton CN, Wunder JS, et al. Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma. J Clin Oncol. 2002;20(22):4472–7. Epub 2002/11/15.CrossRefPubMed
63.
Sadoski C, Suit HD, Rosenberg A, Mankin H, Efird J. Preoperative radiation, surgical margins, and local control of extremity sarcomas of soft tissues. J Surg Oncol. 1993;52(4):223–30. Epub 1993/04/01.CrossRefPubMed
64.
Al Yami A, Griffin AM, Ferguson PC, Catton CN, Chung PW, Bell RS, et al. Positive surgical margins in soft tissue sarcoma treated with preoperative radiation: is a postoperative boost necessary? Int J Radiat Oncol Biol Phys. 2010;77(4):1191–7.CrossRefPubMed
65.
Alamanda VK, Song Y, Shinohara E, Schwartz HS, Holt GE. Postoperative radiation boost does not improve local recurrence rates in extremity soft tissue sarcomas. J Med Imaging Radiat Oncol. 2014;58(5):633–40.CrossRefPubMed
66.
Davis AM, O'Sullivan B, Turcotte R, Bell R, Catton C, Chabot P, et al. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol. 2005;75(1):48–53. Epub 2005/06/11.CrossRefPubMed
67.
Alektiar KM, Velasco J, Zelefsky MJ, Woodruff JM, Lewis JJ, Brennan MF. Adjuvant radiotherapy for margin-positive high-grade soft tissue sarcoma of the extremity. Int J Radiat Oncol Biol Phys. 2000;48(4):1051–8. Epub 2000/11/10.CrossRefPubMed
68.
Jebsen NL, Trovik CS, Bauer HC, Rydholm A, Monge OR, Hall KS, et al. Radiotherapy to improve local control regardless of surgical margin and malignancy grade in extremity and trunk wall soft tissue sarcoma: a Scandinavian sarcoma group study. Int J Radiat Oncol Biol Phys. 2008;71(4):1196–203.CrossRefPubMed
69.
Ballo MT, Zagars GK, Cormier JN, Hunt KK, Feig BW, Patel SR, Pisters PW. Interval between surgery and radiotherapy: Effect on local control of soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 2004;58(5):1461–7.CrossRefPubMed
70.
Sampath S, Schultheiss TE, Hitchcock YJ, Randall RL, Shrieve DC, Wong JY. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma: multi-institutional analysis of 821 patients. Int J Radiat Oncol Biol Phys. 2011;81(2):498–505.CrossRefPubMed
71.
Cheng EY, Dusenbery KE, Winters MR, Thompson RC. Soft tissue sarcomas: preoperative versus postoperative radiotherapy. J Surg Oncol. 1996;61(2):90–9.CrossRefPubMed
72.
Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS. Preoperative vs. postoperative radiation therapy for soft tissue sarcoma: a retrospective comparative evaluation of disease outcome. Int J Radiat Oncol Biol Phys. 2003;56(2):482–8.CrossRefPubMed
73.
Guadagnolo BA, Zagars GK, Ballo MT, Patel SR, Lewis VO, Pisters PW, et al. Long-term outcomes for synovial sarcoma treated with conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2007;69(4):1173–80.CrossRefPubMed
74.
Greene FL, Compton CC, Fritz AG, Shah JP, Winchester DP. AJCC cancer staging atlas. 7th ed. 2006.CrossRef